BackBackDiluted net income available to common stockholders of SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.LTD
Annual data
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
0.00
60.00 M
120.00 M
180.00 M
240.00 M
Period
Value
Change
Change %
TTM
105.20 M
−3.42 M
−3.15%
2023
108.63 M
−29.37 M
−21.28%
2022
138.00 M
−75.30 M
−35.30%
2021
213.30 M
+48.63 M
+29.53%
2020
164.66 M
−62.70 M
−27.58%
2019
227.36 M
+115.23 M
+102.76%
Quarterly data
Q1 '12
Q2 '12
Q3 '12
Q4 '12
Q1 '13
Q2 '13
Q3 '13
Q2 '14
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
26.00 M
52.00 M
78.00 M
104.00 M
Period
Value
Change
Change %
Q3 '24
16.00 M
−52.13 M
−76.52%
Q2 '24
68.13 M
+65.78 M
+2.80 K%
Q1 '24
2.35 M
−16.39 M
−87.47%
Q4 '23
18.74 M
−2.72 M
−12.67%
Q3 '23
21.45 M
−38.20 M
−64.03%
Q2 '23
59.65 M
+50.86 M
+578.84%
Q1 '23
8.79 M
−92.39 M
−91.31%
Q4 '22
101.17 M
+28.37 M
+38.98%